Primary chemotherapy in the individualized non-mutilating treatment of breast cancer
Author:
Publisher
Springer Paris
Link
http://link.springer.com/content/pdf/10.1007/978-2-8178-0765-2_21
Reference14 articles.
1. Bonadonna G, Veronesi U, Bramvilla C et al. Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimeters or more. J Natl Cancer Inst 82: 1539–1545
2. Early Breast Cancer Trialist’s collaborative Group (1988) Effects of adjuvant Tamoxifen and cytoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 319: 1681–1692
3. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N et al (1985) Five-year results on a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312: 665–673
4. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M et al (1989) Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320: 822–828
5. Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S et al (1989) A randomized clinical trials evaluating sequential Methotrexate and Fluorouracil in the treatment of patients with node negative breast cancer who have estrogen receptor negative tumors. N Engl J Med 320: 473–478
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3